Melnikov V G, Villena J, Kombarova S Y
G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology of Rospotrebnadzor, 125212, Moscow, Russian Federation.
Immunobiotics Research Group, Reference Centre for Lactobacilli (CERELA-CONICET), 980-0845, Tucuman, Argentina.
Klin Lab Diagn. 2019;64(11):693-699. doi: 10.18821/0869-2084-2019-64-11-693-699.
Staphylococcus aureus asymptomatically persists on the nasal mucosa, and also causes serious diseases in carriers (endogenous infection) and in patients in a hospital (nosocomial infection). Decolonization of nasal carriers of S. aureus is an important measure aimed at reducing the incidence of staphylococcal infections. Carriage is a form of nasal dysbiosis, therefore, the effectiveness of antibiotics for the decolonization of carriers, by definition, is low. The review discusses the prospects of using probiotics to restore the nasal microbiota. The commercial production of nasal probiotics has not yet been established, but developments in this direction are being carried out in different countries. The experimental substantiation of the possibility of using corynebacteria and other representatives of the nasal microbiota for the decolonization of staphylococcal carriers is presented, as well as the authors' ideas on how to improve the methods of microbial therapy. In particular, it was proposed to use biofilm probiotics, autoprobiotics, and autovaccines for this purpose.
金黄色葡萄球菌可无症状地持续存在于鼻黏膜上,还会在携带者中引发严重疾病(内源性感染)以及在医院患者中引发感染(医院感染)。对金黄色葡萄球菌鼻腔携带者进行去定植是降低葡萄球菌感染发病率的一项重要措施。携带状态是鼻微生物群失调的一种形式,因此,从定义上来说,抗生素对携带者去定植的效果较低。本综述探讨了使用益生菌来恢复鼻腔微生物群的前景。鼻腔益生菌的商业化生产尚未确立,但不同国家正在朝这个方向开展研究。文中介绍了使用棒状杆菌和鼻腔微生物群的其他代表菌株对葡萄球菌携带者进行去定植可能性的实验依据,以及作者关于如何改进微生物治疗方法的观点。特别是,为此提议使用生物膜益生菌、自身益生菌和自身疫苗。